Vaxil Bio Ltd. (VXL.V)
0.16
0.00 (0.00%)
CAD |
TSXV |
Aug 24, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.6374M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 0.00% |
| Valuation | |
| PE Ratio | 1.268 |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 0.5067 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.63% |
Profile
| Vaxil Bio Ltd. is a biotechnology company engaged in the development of signal peptide-based immunotherapies for the treatment of cancer and infectious diseases. Its pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on July 26, 2006 and is headquartered in Toronto, Canada. |
| URL | N/A |
| Investor Relations URL | http://vxlbio.com/investor-center/ |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Growth |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Vaxil Bio Ltd. is a biotechnology company engaged in the development of signal peptide-based immunotherapies for the treatment of cancer and infectious diseases. Its pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on July 26, 2006 and is headquartered in Toronto, Canada. |
| URL | N/A |
| Investor Relations URL | http://vxlbio.com/investor-center/ |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Growth |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |